Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

KYG7487R1002
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG00ZS40360
RGC

Regencell Bioscience Holdings
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Drug Manufacturers—Specialty & Generic · THEMEFOLIO: $HLTH
NAME
Regencell Bioscience Holdings
ISIN
KYG7487R1002
TICKER
RGC
MIC
XNAS
REUTERS
RGC.OQ
BLOOMBERG
RGC US
Sun, 03.05.2026       Regencell Bioscience

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regencell To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Regencell between October 28, 2024 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi part...
Sun, 03.05.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - May 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has alre...
Sat, 02.05.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - May 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has already b...
Fri, 01.05.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - May 1, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleged...
Fri, 01.05.2026       Regencell Bioscience

NEW YORK, April 30, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC) and certain officers.   The class action, filed in the United States District Court for the District of Maryland, and docketed under 26-cv-01602, is o...
Thu, 30.04.2026       Regencell Bioscience

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR...
Thu, 30.04.2026       Regencell Bioscience

Law Offices of Howard G. Smith announces an investigation on behalf of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC), CONTACT THE LAW OFF...
Thu, 30.04.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - April 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has a...
Wed, 29.04.2026       Regencell Bioscience

The Law Offices of Frank R. Cruz announces an investigation of Regencell Bioscience Holdings Limited (“Regencell” or the “Company”) (NASDAQ: RGC) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON REGENCELL BIOSCIENCE HOLDINGS LIMITED (RGC), CLICK HERE TO INQUIRE A...
Wed, 29.04.2026       Regencell Bioscience

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regencell To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Regencell between October 28, 2024 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi part...
Silent Ad
Wed, 29.04.2026       Regencell Bioscience

NEW YORK, April 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Regencell Bioscience Holdings Limited ("Regencell Bioscience Holdings Limited" or the "Company") (NASDAQ: RGC) of a class action securities lawsuit....
Wed, 29.04.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - April 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the "Class Period"). A class action lawsuit has alread...
Tue, 28.04.2026       Regencell Bioscience

New York, New York--(Newsfile Corp. - April 28, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) and certain of its officers.This lawsuit seeks to recover damages against Defendants for alleg...
Tue, 28.04.2026       Regencell Bioscience

SAN DIEGO, April 27, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the...
Tue, 28.04.2026       Regencell Bioscience

Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”). Regencell is a purported early-stage bioscience company. For more information, s...
Sat, 25.04.2026       Regencell Bioscience

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercializatio...
Thu, 20.11.2025       Regencell Bioscience

NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....